Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP3417461B2 - Soy protein hydrolyzate, method for producing the same, and foods using the same - Google Patents
[go: Go Back, main page]

JP3417461B2 - Soy protein hydrolyzate, method for producing the same, and foods using the same - Google Patents

Soy protein hydrolyzate, method for producing the same, and foods using the same

Info

Publication number
JP3417461B2
JP3417461B2 JP35395897A JP35395897A JP3417461B2 JP 3417461 B2 JP3417461 B2 JP 3417461B2 JP 35395897 A JP35395897 A JP 35395897A JP 35395897 A JP35395897 A JP 35395897A JP 3417461 B2 JP3417461 B2 JP 3417461B2
Authority
JP
Japan
Prior art keywords
protein
soybean protein
soybean
amount
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP35395897A
Other languages
Japanese (ja)
Other versions
JPH11178512A (en
Inventor
和伸 津村
渉 釘宮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc)
Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc)
Original Assignee
Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc)
Fuji Oil Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc), Fuji Oil Co Ltd filed Critical Fuji Oil Co Ltd (fka Fuji Oil Holdings Inc)
Priority to JP35395897A priority Critical patent/JP3417461B2/en
Publication of JPH11178512A publication Critical patent/JPH11178512A/en
Application granted granted Critical
Publication of JP3417461B2 publication Critical patent/JP3417461B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Beans For Foods Or Fodder (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、大豆蛋白の主要ア
レルゲンであるβ-コングリシニン且つGly m Bd30Kが分
解された大豆蛋白分解物及びそれを用いた食品に関す
る。
TECHNICAL FIELD The present invention relates to a soybean protein degradation product obtained by degrading β-conglycinin and Gly m Bd30K, which are major allergens of soybean protein, and a food product using the same.

【0002】[0002]

【従来の技術】近年、特定の食物を食した時に鼻炎、湿
疹、下痢及びじんましん等の異常な過敏反応を生じ、時
として重篤な病的状態となる所謂食物アレルギー患者が
増加している。これらの治療方法として、薬物による対
症療法やアレルゲンとなる原因物質を患者の食餌から取
り除く所謂除去食物療法がある。食物性アレルギーの中
でも卵、牛乳、大豆に含まれる特定の蛋白質が3大アレ
ルゲンとして認識されていることから、除去食物療法を
導入するのが一般的であるが、上記アレルゲンの中でも
大豆蛋白質は、豆腐、凍豆腐、湯葉等といった日本の伝
統的食品やこれを原料として含む広い食品に含まれるこ
と、更には大豆蛋白の機能、例えば乳化性、ゲル形成
性、保水性、保油性、起泡性等といった機能性を利用し
た大豆蛋白利用食品が急増している近年にあっては、除
去食物療法を容易ならざるものにしている。
2. Description of the Related Art In recent years, an increasing number of so-called food allergic patients have an abnormal hypersensitivity reaction such as rhinitis, eczema, diarrhea and urticaria when eating a specific food, and sometimes become a serious morbid state. These treatment methods include symptomatic treatment with drugs and so-called elimination food therapy for removing causative substances that become allergens from the patient's diet. Among food allergies, eggs, milk, since specific proteins contained in soybeans are recognized as the three major allergens, it is common to introduce elimination food therapy, but among the above allergens, soy protein is Included in traditional Japanese foods such as tofu, frozen tofu, and yuba, and a wide range of foods containing this as a raw material, as well as the function of soybean proteins, such as emulsifying property, gel forming property, water retention property, oil retention property, and foaming property. In recent years, the number of foods that use soybean proteins that utilize such functionality has rapidly increased, making elimination diet therapy difficult.

【0003】ところで大豆アレルゲン蛋白質は、大豆に
対するアトピー性疾患をもつ患者から得たIgE抗体に対
して反応性の高い大豆蛋白質成分として、Gly m Bd 30K
を始め、β-コングリシニンのαサブユニットやβサブ
ユニット等と同定されたことが報告されている (J.Nutr.Sci.Vitaminol.,555-565(1991))。
By the way, soybean allergen protein is Gly m Bd 30K as a soybean protein component having high reactivity with IgE antibody obtained from a patient with atopic disease to soybean.
It has been reported that the α subunit and β subunit of β-conglycinin were identified (J. Nutr. Sci. Vitaminol., 555-565 (1991)).

【0004】これら大豆アレルゲン蛋白質の内、最もア
レルギー患者の発病頻度の高いGlym Bd 30Kと称される
蛋白質を大豆から分離或いは分解し、低アレルゲン化す
る試みがなされている。例えば、豆乳からのアレルゲン
除去として特開平7-236444号公報、特開平7-236449号公
報、特開平8-308506号公報のように、Gly m Bd 30Kが豆
乳中の脂質成分と親和性が高く、高い遠心加速度の下で
上清に移行することを利用する方法が開示されている。
また、特開平7-236427号公報、特開平9-37720号公報の
ように特定のpH及びイオン強度で主要貯蔵蛋白質の7Sと
11S画分とGly mBd 30Kの溶解度の違いを利用する方法が
開示されている。
Among these soybean allergen proteins, an attempt has been made to reduce the allergen by separating or degrading a protein called Glym Bd 30K, which has the highest frequency of onset in allergic patients, from soybean. For example, as an allergen removal from soy milk, JP 7-236444 JP, JP 7-236449, JP 8-308506, Gly m Bd 30K has a high affinity with the lipid component in soy milk. , A method utilizing transfer to supernatant under high centrifugal acceleration is disclosed.
Further, as described in JP-A-7-236427 and JP-A-9-37720, 7S of the main storage protein at a specific pH and ionic strength is used.
A method utilizing the difference in solubility between the 11S fraction and Gly mBd 30K is disclosed.

【0005】酵素によりGly m Bd 30Kを分解する試みと
しては特開平6-253758号公報、特開平7-203890号公報、
特開平7-236439号公報、特開平8-56600号公報、特開平9
-23822号公報のように加熱変性を施した大豆や大豆蛋白
にプロテアーゼを作用させる方法が知られている。
As an attempt to decompose Gly m Bd 30K with an enzyme, JP-A-6-253758, JP-A-7-203890,
JP-A-7-236439, JP-A-8-56600, JP-A-9
There is known a method in which a protease is allowed to act on soybean or soybean protein that has been heat-denatured as described in Japanese Patent No. 23822.

【0006】しかし上記の方法では、Gly m Bd 30Kを分
離する為には高い遠心加速度が必要なことや7Sと11S画
分とGly m Bd 30Kの分離に高イオン強度が必要で、その
後に脱塩工程が必要とされる為、工業的には難点がある
ことやGly m Bd 30Kに次いでアレルギー患者の発病頻度
の高いβ-コングリシニンが依然残ったままになってい
る。また、酵素によりGly m Bd 30Kを分解する方法では
加熱変性を施した大豆や大豆蛋白にプロテアーゼを作用
させるので、Gly m Bd 30Kだけでなく主要貯蔵蛋白質の
7Sと11S画分ともに分解されてしまい大豆蛋白の食品に
適した物性、例えばゲル形成性等が殆ど失われてしまい
用途が限られてしまう欠点があった。
However, in the above method, a high centrifugal acceleration is required to separate Gly m Bd 30K and a high ionic strength is required to separate the 7S and 11S fractions from Gly m Bd 30K. Since a salt process is required, there are industrial difficulties, and β-conglycinin, which has a high frequency of onset in allergic patients, remains next to Gly m Bd 30K. Also, in the method of degrading Gly m Bd 30K with an enzyme, a protease acts on soybeans and soybean proteins that have been heat-denatured, so that not only Gly m Bd 30K but also the major storage protein
Both the 7S and 11S fractions were decomposed, and the physical properties of soybean protein suitable for foods, such as gel forming property, were almost lost, and there was a drawback that the use was limited.

【0007】[0007]

【発明が解決しようとする課題】以上の実情に鑑み、本
発明は大豆蛋白の主要アレルゲンであるβ-コングリシ
ニン且つGly m Bd 30Kが分解された低アレルゲン大豆蛋
白分解物及びそれを用いた食品を目的とする。 → 以上の実情に鑑み、本発明は大豆蛋白の主要アレル
ゲンが揃って分解され且つ非アレルゲンが殆ど分解され
ない大豆蛋白分解物及びそれを用いた食品を目的とす
る。
In view of the above circumstances, the present invention provides a low allergen soybean protein hydrolyzate in which β-conglycinin and Gly m Bd 30K, which are major allergens of soybean protein, are decomposed, and a food using the same. To aim. In view of the above circumstances, the present invention aims at a soybean protein decomposition product in which major allergens of soybean protein are uniformly decomposed and non-allergens are hardly decomposed, and a food using the same.

【0008】[0008]

【課題を解決するための手段】本発明者らは、上記課題
を解決すべく鋭意研究した結果、大豆蛋白にプロテアー
ゼを特定の条件下に作用させることにより、大豆蛋白中
のβ-コングリシニン且つGly m Bd 30Kを選択的に分解
することが出来、目的の大豆蛋白分解物を得ることが出
来る知見を得て、本発明を完成するに至った。
[Means for Solving the Problems] As a result of intensive studies to solve the above problems, the present inventors have found that β-conglycinin and Gly in soybean protein can be obtained by allowing a protease to act on soybean protein under specific conditions. The present invention has been completed based on the finding that m Bd 30 K can be selectively decomposed and a target soybean protein hydrolyzate can be obtained.

【0009】即ち、本発明は、大豆蛋白中のβ-コング
リシニン量に対するグリシニン量の比が5以上且つ大豆
蛋白中の粗蛋白量に対するGly m Bd 30K量の比が0.5
%以下である大豆蛋白分解物である。大豆蛋白中のβ-
コングリシニン量に対するグリシニン量の比が5以上且
つ大豆蛋白中の粗蛋白量に対するGly m Bd 30K量が0.
5%以下で、0.22Mトリクロロ酢酸可溶窒素率が5〜30%
である大豆蛋白分解物が好ましい。又、本発明は、上記
の大豆蛋白分解物を蛋白原料の一部または全部として含
有する大豆蛋白分解物利用食品である。又、本発明は、
低変性大豆蛋白を50℃を越え90℃未満及び枯草菌(納豆
菌)に由来するプロテアーゼで分解することを特徴とす
る大豆蛋白分解物の製造法である。低変性脱脂大豆のNS
I(窒素可溶係数)は60以上が好ましい。分解後の反応
液のTCA%が5〜30%となるように分解することが好ま
し。pH=5〜10で5分〜2時間分解することが好ましい。
That is, in the present invention, the ratio of the amount of glycinin to the amount of β-conglycinin in soybean protein is 5 or more, and the ratio of Gly m Bd 30K amount to the amount of crude protein in soybean protein is 0.5.
It is a soy protein hydrolyzate having a content of not more than%. Β- in soy protein
The ratio of the amount of glycinin to the amount of conglycinin is 5 or more and the amount of Gly m Bd 30K to the amount of crude protein in soybean protein is 0.
At 5% or less, 0.22M trichloroacetic acid soluble nitrogen rate is 5 to 30%
The soybean protein degradation product is preferred. The present invention also provides a soybean protein hydrolyzate-containing food containing the soybean protein hydrolyzate as part or all of the protein raw material. The present invention also provides
A method for producing a soybean protein hydrolyzate, which comprises degrading low-denatured soybean protein with a protease derived from Bacillus subtilis (natto) above 50 ° C and below 90 ° C. Low-denaturation defatted soybean NS
I (nitrogen solubility coefficient) is preferably 60 or more. It is preferable to decompose so that the TCA% of the reaction solution after decomposition becomes 5 to 30%. It is preferable to decompose at pH = 5 to 10 for 5 minutes to 2 hours.

【0010】[0010]

【発明の実施の形態】本発明の大豆蛋白分解物は、大豆
蛋白の主要アレルゲンであるβ-コングリシニン且つGly
m Bd 30Kが分解され低減されている。
BEST MODE FOR CARRYING OUT THE INVENTION The soybean protein degradation product of the present invention comprises β-conglycinin and Gly which are major allergens of soybean protein.
m Bd 30K is decomposed and reduced.

【0011】一般に大豆中の主要貯蔵蛋白であるグリシ
ニンとβ-コングリシニンは、例えば米国産の一般的な
大豆である場合、通常その成分比はグリシニン/β-コ
ングリシニン比=1.3〜1.5であり、その加工製品もその
成分比を保っている。
In general, the major storage proteins in soybean, glycinin and β-conglycinin, for example, in the case of general soybeans produced in the United States, the component ratio is usually glycinin / β-conglycinin ratio = 1.3 to 1.5. Processed products also maintain their component ratio.

【0012】本発明の大豆蛋白分解物は、β-コングリ
シニンが選択的に分解されているので、その比は5以上
である。
The soybean protein hydrolyzate of the present invention has a ratio of 5 or more because β-conglycinin is selectively decomposed.

【0013】また、Gly m Bd 30K量は大豆蛋白の粗蛋白
量(ケルダール窒素量×6.25)に対して通常約2%存在
するが、本発明の大豆蛋白分解物ではGly m Bd 30Kが選
択的に分解されているので、その粗蛋白量に対して0.5
%以下、好ましくは0.2%以下である。
The amount of Gly m Bd 30K is usually about 2% with respect to the amount of crude protein of soybean protein (Kjeldahl nitrogen amount x 6.25), but Gly m Bd 30K is selectively present in the soybean protein hydrolyzate of the present invention. Since it has been decomposed into
% Or less, preferably 0.2% or less.

【0014】大豆蛋白中の各成分の含量変化を調べる方
法としては、大豆蛋白をSDS-電気泳動法により各成分に
分離することで評価できる。β-コングリシニン及びグ
リシニンの場合、SDS-電気泳動ゲルをクマシーブルー染
色して、β-コングリシニン、グリシニン及びその他の
蛋白のバンドの濃淡をデンシトメーターで測定し、全エ
リア面積に対するβ-コングリシニン及びグリシニンの
エリア面積比からグリシニン/β-コングリシニン比を
求めることができる。
A method for investigating the change in the content of each component in soybean protein can be evaluated by separating soybean protein into each component by SDS-electrophoresis. In the case of β-conglycinin and glycinin, SDS-electrophoresis gel was stained with Coomassie blue, and the density of bands of β-conglycinin, glycinin and other proteins was measured with a densitometer, and β-conglycinin and glycinin for the entire area of the area were measured. The glycinin / β-conglycinin ratio can be determined from the area area ratio of.

【0015】また、Gly m Bd 30Kの場合は、同様に大豆
蛋白をSDS-電気泳動法により分離したゲルからGly m Bd
30K蛋白をPVDF(ポリビニリジンジフルオライド)膜に
転写し、Gly m Bd 30Kのモノクローナル抗体を用いるEC
L法(Amersham製)により検出(ペルオキシダーゼによ
る蛍光発光をX線フィルムで感知)する方法が感度良く
測定可能である(特開平7-236427号公報の方法を参
照)。そしてその含量は、精製したGly m Bd 30K蛋白
(Gly m Bd 30K蛋白の精製は、T.Ogawa et.al.,Biosci.
Biotech.Biochem.,57,1030(1993)を基に実施できる)を
用い、各粗蛋白質量をSDS-電気泳動し上記方法で検出し
たバンドの濃淡をデンシトメーターで測定したバンドエ
リア面積を基に検量線を作成すると、Gly m Bd 30K蛋白
の粗蛋白質量に対するGly m Bd 30K蛋白のバンドエリア
面積が比例し、Gly m Bd 30K蛋白量が算出できる。そし
て、粗蛋白質量既知の大豆蛋白を上記方法で検出し、Gl
y m Bd 30K蛋白のバンドエリア面積を調べると検量線か
らGly m Bd 30K蛋白量が算出でき、粗蛋白質に対するGl
y m Bd 30K量(以下Gly m Bd 30K%とする)が求められ
る。
Further, in the case of Gly m Bd 30K, Gly m Bd was similarly extracted from a gel obtained by separating soybean protein by SDS-electrophoresis.
EC using 30K protein transferred to PVDF (polyvinylidin difluoride) membrane and Gly m Bd 30K monoclonal antibody
A method of detecting by L method (manufactured by Amersham) (sensing fluorescence emission by peroxidase with an X-ray film) can be measured with high sensitivity (see the method of JP-A-7-236427). And the content is the purified Gly m Bd 30K protein (Gly m Bd 30K protein is purified by T. Ogawa et.al., Biosci.
Biotech.Biochem., 57, 1030 (1993)), and the density of each of the crude proteins detected by SDS-electrophoresis and the density detected by the above method was measured using a densitometer. When a calibration curve is prepared in Fig. 3, the band area area of the Gly m Bd 30K protein is proportional to the crude protein mass of the Gly m Bd 30K protein, and the Gly m Bd 30K protein amount can be calculated. Then, the soybean protein with a known crude protein amount was detected by the above method, and Gl
The amount of Gly m Bd 30K protein can be calculated from the calibration curve by examining the band area area of ym Bd 30K protein.
The amount of ym Bd 30K (hereinafter referred to as Gly m Bd 30K%) is required.

【0016】また本発明の大豆蛋白分解物では、0.22M
トリクロロ酢酸可溶窒素率(以下TCA%とする)では5〜
30%、好ましくは7〜20%程度の分解がされている。
The soybean protein hydrolyzate of the present invention contains 0.22M.
Trichloroacetic acid soluble nitrogen rate (TCA% below) is 5 ~
Degradation of 30%, preferably 7 to 20%.

【0017】次に、本発明は上記の大豆蛋白分解物を蛋
白原料の一部または全部として含有する大豆蛋白分解物
利用食品である。
Next, the present invention is a soybean protein degradation product-containing food containing the above-mentioned soybean protein degradation product as a part or all of the protein raw material.

【0018】本発明の大豆蛋白分解物は、大豆蛋白の主
要アレルゲンであるβ-コングリシニン且つGly m Bd 30
Kが分解され、アレルゲンではないグリシニンが殆ど分
解されていないので、従来大豆蛋白が用いられてきた食
品一般に広く使用することが出来る。
The soybean protein hydrolyzate of the present invention contains β-conglycinin and Gly m Bd 30 which are major allergens of soybean protein.
Since K is decomposed and glycinin, which is not an allergen, is hardly decomposed, it can be widely used for general foods in which soybean protein has been conventionally used.

【0019】大豆蛋白使用食品としては、例えば豆腐、
油揚げ、がんもどき等の他、ハム、ソーセージ、ハンバ
ーグ、ミートボール等の畜肉製品、かまぼこ、揚げかま
ぼこ、竹輪といった水産練り製品や惣菜等、プロテイン
ドリンク、育児粉乳等の飲料等が例示される。これら大
豆蛋白分解物を使用した食品は、含まれている大豆蛋白
の量にもよるが、本発明の大豆蛋白分解物以外のこれま
での大豆蛋白を使用した食品中に含まれる大豆アレルゲ
ンの10%以下にまで低減されているので、大豆食物性ア
レルギー患者への除去食物療法に適している。
Examples of soy protein-containing foods include tofu,
In addition to fried foods, cancerous foods, etc., meat products such as ham, sausages, hamburgers, meatballs, fish paste products such as kamaboko, fried kamaboko and bamboo rings, and prepared foods, protein drinks, baby milk powder and other beverages are exemplified. Foods using these soybean protein decomposition products, depending on the amount of soybean protein contained, 10 soybean allergens contained in foods using soybean protein other than the soybean protein decomposition product of the present invention. Since it is reduced to less than 10%, it is suitable for elimination diet therapy for soybean food allergy patients.

【0020】尚、本発明の大豆蛋白分解物の製造法の一
例を以下に記載する。先ず、低変性大豆蛋白を特定の温
度範囲及び特定のプロテアーゼで分解することで大豆蛋
白の主要構成成分のグリシニンを殆ど分解させずに、大
豆蛋白の主要アレルゲンであるβ-コングリシニン且つG
ly m Bd 30Kのみを選択的に分解する方法が挙げられ
る。
An example of the method for producing the soybean protein hydrolyzate of the present invention will be described below. First, by degrading low-denatured soybean protein with a specific temperature range and with a specific protease, glycinin, which is a main component of soybean protein, is hardly decomposed, and β-conglycinin and G, which are the main allergens of soybean protein, are decomposed.
There is a method of selectively decomposing only ly m Bd 30K.

【0021】この方法に於いて、反応温度が重要で50℃
を越え90℃未満、好ましくは60〜80℃に於いて酵素反応
を行うことが適当である。この温度以下では、β-コン
グリシニン、Gly m Bd 30Kの分解度が低く、またこれ以
上或いは過度に加熱された変性大豆蛋白ではβ-コング
リシニン、Gly m Bd 30Kのみならずグリシニンも分解さ
れ、大豆蛋白の主要アレルゲンであるβ-コングリシニ
ン且つGly m Bd 30Kのみを選択的に分解することが出来
なくなり、大豆蛋白が本来有している機能性、例えばゲ
ル形成性等が殆ど失われてしまう。従って、使用される
大豆蛋白としては大豆、大豆蛋白を主体とする全脂豆
乳、脱脂豆乳、濃縮大豆蛋白、分離大豆蛋白等である
が、蛋白変性を伴わないまたは低変性にとどめた加工処
理を行った大豆加工品が好ましく、品種、産地等には限
定されない。一般的には、大豆をN-ヘキサンを抽出溶剤
として低温抽出処理を行った脱脂大豆が原料として適当
であり、特にNSI(窒素可溶係数)が60以上、好ましく
は80以上の低変性脱脂大豆から水抽出した脱脂豆乳や濃
縮大豆蛋白、分離大豆蛋白が好適に用いられる。
In this method, the reaction temperature is important and the temperature is 50 ° C.
It is suitable to carry out the enzyme reaction at a temperature above 90 ° C and below 90 ° C, preferably 60 to 80 ° C. Below this temperature, the degree of decomposition of β-conglycinin, Gly m Bd 30K is low, and in denatured soybean protein above this or excessively heated, β-conglycinin, Gly m Bd 30K as well as glycinin are decomposed, and soybean protein is decomposed. Β-conglycinin and Gly m Bd 30K, which are major allergens of soybean, cannot be selectively decomposed, and the functionality originally possessed by soybean proteins, such as gel-forming property, is almost lost. Therefore, as the soybean protein used, soybean, full-fat soybean milk mainly composed of soybean protein, defatted soybean milk, concentrated soybean protein, soybean protein isolate, etc., but the processing treatment without protein denaturation or limited to low denaturation The processed soybean product is preferable, and it is not limited to a variety, a production area, or the like. Generally, defatted soybean obtained by subjecting soybean to low-temperature extraction treatment with N-hexane as an extraction solvent is suitable as a raw material, and in particular, a low-denaturation defatted soybean having an NSI (nitrogen solubility coefficient) of 60 or more, preferably 80 or more. Skim soy milk extracted from water with water, concentrated soy protein, and isolated soy protein are preferably used.

【0022】用いるプロテアーゼは、50℃を越え90℃未
満、好ましくは60〜80℃に於いて蛋白質分解活性を有す
る酵素または酵素剤であることが必要で、とりわけ枯草
菌(納豆菌)に由来するプロテアーゼであるズブチリシ
ンや市販プロテアーゼであるプロチン(商品名;大和化
成社製)、プロレザー(商品名;天野製薬社製)等の枯
草菌由来のプロテアーゼが好適に使用される。これら枯
草菌(納豆菌)に由来するプロテアーゼは上記の反応温
度で大豆蛋白の主要アレルゲンであるβ-コングリシニ
ン且つGly m Bd 30Kを選択的に分解出来る。
The protease to be used must be an enzyme or enzyme agent having a proteolytic activity at a temperature higher than 50 ° C. and lower than 90 ° C., preferably 60 to 80 ° C., and is derived from Bacillus subtilis (natto). Protease derived from Bacillus subtilis such as subtilisin which is a protease, protin (trade name; manufactured by Daiwa Kasei Co., Ltd.) which is a commercially available protease, and proleather (trade name; manufactured by Amano Pharmaceutical Co., Ltd.) is preferably used. Proteases derived from these Bacillus subtilis (natto) can selectively decompose β-conglycinin and Gly m Bd 30K, which are the major allergens of soybean protein, at the above reaction temperature.

【0023】酵素反応工程は、大豆蛋白の製造工程中に
実施される。例えば分離大豆蛋白を製造する場合では、
低変性脱脂大豆から水抽出した脱脂豆乳を等電点沈殿し
て得た酸沈殿カードに加水・中和した懸濁液を50℃を越
え90℃未満、好ましくは60〜80℃に調整し、プロテアー
ゼを加え、分解反応を実施する。反応終了後、反応液を
殺菌(酵素の失活も兼ねる)し、必要あれば乾燥を行
う。また、反応液をグリシニンの等電点であるpH6付近
で分画、沈殿画分を採取し、加水・中和・殺菌し、必要
あれば乾燥を行うこともできる。プロテアーゼの添加量
や反応pHや反応時間は、β-コングリシニン且つGly m B
d 30Kの分解程度から決定すればよいが、分解後の反応
液のTCA%は5〜30%、好ましくは7〜20%程度の分解が
目安となる。一般的には、プロテアーゼの添加量は大豆
蛋白懸濁液の固形分に対して、0.001〜1%、好ましくは
0.01〜0.5%の範囲で、反応pHも用いる酵素剤の至適pH
や安定pHから、通常pH=5〜10、好ましくはpH=6〜9
で、5分〜2時間、好ましくは10分〜1時間反応させれば
よく、プロテアーゼを固定化したカラムに通液すること
で連続反応も実施できる。
The enzyme reaction step is carried out during the soybean protein production step. For example, when producing isolated soy protein,
A suspension of water-neutralized acid-precipitated curd obtained by isoelectric precipitation of defatted soymilk extracted with water from low-denaturation defatted soybeans is adjusted to more than 50 ° C and less than 90 ° C, preferably 60 to 80 ° C. Protease is added and the degradation reaction is carried out. After the completion of the reaction, the reaction solution is sterilized (also serves to inactivate the enzyme) and dried if necessary. Further, the reaction solution can be fractionated at around pH 6 which is the isoelectric point of glycinin, and the precipitated fraction can be collected, hydrated, neutralized and sterilized, and dried if necessary. The amount of protease added, the reaction pH, and the reaction time depend on β-conglycinin and Gly m B
Although it may be determined from the degree of decomposition of d 30K, the TCA% of the reaction solution after decomposition is 5 to 30%, preferably about 7 to 20%. Generally, the amount of protease added is 0.001 to 1% with respect to the solid content of the soybean protein suspension, preferably
Optimum pH of enzyme agent that uses reaction pH in the range of 0.01 to 0.5%
Or stable pH, usually pH = 5-10, preferably pH = 6-9
Then, the reaction may be carried out for 5 minutes to 2 hours, preferably 10 minutes to 1 hour, and continuous reaction can also be carried out by passing the solution through a column on which protease is immobilized.

【0024】[0024]

【実施例】以下、実施例により本発明の実施様態を具体
的に説明するが、本発明がこれらによってその技術範囲
が限定されるものではない。
EXAMPLES Hereinafter, the embodiments of the present invention will be specifically described with reference to Examples, but the technical scope of the present invention is not limited by these.

【0025】製造例1 N-ヘキサンで脱脂された低変性脱脂大豆(窒素可溶係
数;NSI>80)10Kgに10倍量の水を加え、室温、pH7で1
時間抽出後、遠心分離し、脱脂豆乳95Kgを得た。これに
塩酸を加え、pH4.5に調整し、遠心分離してホエーを除
き酸沈殿カード10Kgを得た。該酸沈殿カードに加水し、
20%NaOHでpH7に調整後、懸濁液を70℃に調整して、懸
濁液中の固形物重量当たり0.2%のプロチン(商品名;
大和化成社製)を加え、30分酵素反応を行った。該反応
液を140℃、15秒加熱殺菌した溶液を噴霧乾燥して大豆
蛋白分解物3.5Kgを得た。対照として、上記製造工程で
プロチンを加えて行う酵素反応を除いた方法で大豆蛋白
を得た。 実施例1 上記製造例1で得た大豆蛋白分解物10マイクログラムを
SDS-電気泳動してゲルをクマシーブルー染色してβ-コ
ングリシニンとグリシニンの各バンドの濃淡をデンシト
メーターで定量し、グリシニン/β-コングリシニン比
を求めた。同様に、大豆蛋白分解物2マイクログラムをS
DS-電気泳動したゲルをPVDF膜に転写し、Gly m Bd 30K
のモノクローナル抗体を用いてGly m Bd 30K量を検出・
定量した。グリシニン/β-コングリシニン比=12.7、G
ly m Bd 30K%=0.1%、TCA%=13%であり、β-コング
リシニン、Gly m Bd 30Kのみが低下していた。 実施例2 上記製造例1で得た大豆蛋白分解物8部、水91.7部、グ
ルコノデルタラクトン0.3部を混合、95℃、30分加熱し
て豆腐を調製した。製造例1対照の大豆蛋白で同様に調
製した豆腐に比べ、遜色ない食感であった。 実施例3 上記製造例1で得た大豆蛋白分解物6部、魚肉すり身30
部、大豆油29部、味剤5部、水30部をフードカッターで
混合し、ケーシングチューブに詰め、90℃、30分加熱し
てソーセージを調製した。製造例1対照の大豆蛋白で同
様に調製したソーセージに比べ、遜色ない食感であっ
た。 比較例1及び比較例2 上記製造例1の製造工程で酵素分解の反応温度を37℃と
して行った場合(比較例1)、或いは上記製造例1の製
造工程で酸沈殿カードに加水し、pH7に調整後した懸濁
液を酵素反応に先だって100℃、10分加熱処理をおこな
い、引続き製造例1と同様に酵素反応を行った場合(比
較例2)でそれぞれ大豆蛋白を調製した。実施例1と同
様にして分析したところ、比較例1の大豆蛋白ではグリ
シニン/β-コングリシニン比=1.3、Gly m Bd 30K%=
1.8%、TCA%=6%であり、比較例2の大豆蛋白ではグ
リシニン/β-コングリシニン比=2.6、Gly m Bd 30K%
=0.4%、TCA%=35%であった。 比較例3 比較例2で得た大豆蛋白分解物を用いて、実施例2と同
様の方法で豆腐を調製したが、脆くて食せない状態であ
った。 比較例4 比較例2で得た大豆蛋白分解物を用いて、実施例3と同
様の方法でソーセージを調製したが、製造例1対照の大
豆蛋白で同様に調製したソーセージに比べ、非常に脆い
ものであった。 比較例5 上記製造例1の製造工程で酵素分解に用いるプロテアー
ゼをパパイン(日本バイオコン社製)0.05%の添加に変
更した以外は製造例1と同様行って大豆蛋白分解物を調
製した。実施例1と同様にして分析したところ、比較例
5の大豆蛋白ではグリシニン/β-コングリシニン比=1
3.1、Gly m Bd 30K%=0.6%、TCA%=13%でありGly m
Bd 30Kの低下がやや少ないものであった。
Production Example 1 To 10 kg of low-denaturation defatted soybean (nitrogen solubility coefficient; NSI> 80) defatted with N-hexane was added 10 times the amount of water, and the mixture was adjusted to 1 at room temperature and pH 7.
After time extraction, centrifugation was performed to obtain 95 kg of defatted soy milk. Hydrochloric acid was added to this to adjust the pH to 4.5, and the mixture was centrifuged to remove whey to obtain 10 kg of acid precipitation curd. Add water to the acid precipitation card,
After adjusting the pH to 7 with 20% NaOH, the suspension was adjusted to 70 ° C. and 0.2% protein (trade name;
(Manufactured by Daiwa Kasei Co., Ltd.) was added and the enzyme reaction was carried out for 30 minutes. The reaction solution was sterilized by heating at 140 ° C. for 15 seconds, and the solution was spray-dried to obtain 3.5 kg of a soybean protein decomposition product. As a control, soybean protein was obtained by a method excluding the enzymatic reaction performed by adding protin in the above production process. Example 1 10 micrograms of the soybean protein decomposition product obtained in the above Production Example 1
The gel was stained with Coomassie blue by SDS-electrophoresis, and the density of each band of β-conglycinin and glycinin was quantified with a densitometer to determine the glycinin / β-conglycinin ratio. Similarly, 2 micrograms of soybean protein degradation product
DS-electrophoresed gel was transferred to PVDF membrane and Gly m Bd 30K
Detection of Gly m Bd 30K using monoclonal antibody
It was quantified. Glycinin / β-conglycinin ratio = 12.7, G
LymBd 30K% = 0.1%, TCA% = 13%, and only β-conglycinin and GlymBd 30K were decreased. Example 2 Tofu was prepared by mixing 8 parts of the soybean protein hydrolyzate obtained in the above Production Example 1, 91.7 parts of water and 0.3 part of gluconodeltalactone and heating at 95 ° C. for 30 minutes. Production Example 1 The texture was comparable to that of tofu prepared in the same manner with the control soybean protein. Example 3 6 parts of the soybean protein hydrolyzate obtained in the above Production Example 1, fish meat surimi 30
Part, soybean oil 29 parts, flavoring agent 5 parts, and water 30 parts were mixed with a food cutter, packed in a casing tube, and heated at 90 ° C. for 30 minutes to prepare sausage. Production Example 1 The texture was comparable to that of a sausage prepared in the same manner with the control soybean protein. Comparative Example 1 and Comparative Example 2 When the reaction temperature for enzymatic decomposition was 37 ° C. in the manufacturing process of the above Production Example 1 (Comparative Example 1), or in the manufacturing process of the above Production Example 1, water was added to the acid-precipitated curd to obtain pH 7 Soybean protein was prepared by subjecting the suspensions prepared in step 1 to heat treatment at 100 ° C. for 10 minutes prior to the enzymatic reaction, and subsequently performing the enzymatic reaction in the same manner as in Production Example 1 (Comparative Example 2). When analyzed in the same manner as in Example 1, the soybean protein of Comparative Example 1 had a glycinin / β-conglycinin ratio = 1.3 and Gly m Bd 30K% =
1.8%, TCA% = 6%, and in the soybean protein of Comparative Example 2, glycinin / β-conglycinin ratio = 2.6, Gly m Bd 30K%
= 0.4%, TCA% = 35%. Comparative Example 3 Using the soybean protein decomposition product obtained in Comparative Example 2, tofu was prepared in the same manner as in Example 2, but it was brittle and could not be eaten. Comparative Example 4 A sausage was prepared in the same manner as in Example 3 using the soybean protein degradation product obtained in Comparative Example 2, but was significantly brittle as compared to the sausage prepared in the same manner as in the Production Example 1 control soy protein. It was a thing. Comparative Example 5 A soybean hydrolyzate was prepared in the same manner as in Production Example 1 except that the protease used for enzymatic degradation in the production process of Production Example 1 was changed to 0.05% of papain (manufactured by Nippon Biocon Co., Ltd.). When analyzed in the same manner as in Example 1, the soybean protein of Comparative Example 5 had a glycinin / β-conglycinin ratio of 1
3.1, Gly m Bd 30K% = 0.6%, TCA% = 13% Gly m
The decrease in Bd 30K was slightly small.

【0026】[0026]

【発明の効果】本発明により、大豆蛋白の主要アレルゲ
ンであるβ-コングリシニン且つGly m Bd 30Kが分解さ
れた大豆蛋白分解物及びそれを用いた食品が供給可能と
なり、大豆食物性アレルギー患者への除去食物療法に適
した蛋白源や食品としての利用が可能になったものであ
る。
INDUSTRIAL APPLICABILITY According to the present invention, a soybean protein decomposition product obtained by decomposing β-conglycinin and Gly m Bd 30K, which are major allergens of soybean protein, and a food using the same can be supplied, and it can be applied to soybean food allergy patients. It is now possible to use it as a protein source and food suitable for elimination diet therapy.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A23J 3/16 - 3/14 ─────────────────────────────────────────────────── ─── Continuation of the front page (58) Fields surveyed (Int.Cl. 7 , DB name) A23J 3/16-3/14

Claims (7)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】大豆蛋白中のβ-コングリシニン量に対す
るグリシニン量の比が5以上且つ大豆蛋白中の粗蛋白量
に対するGly m Bd 30K量の比が0.5%以下である大豆
蛋白分解物。
1. A soybean hydrolyzate in which the ratio of the amount of glycinin to the amount of β-conglycinin in soybean protein is 5 or more and the ratio of the amount of Gly m Bd 30K to the amount of crude protein in soybean protein is 0.5% or less.
【請求項2】大豆蛋白中のβ-コングリシニン量に対す
るグリシニン量の比が5以上且つ大豆蛋白中の粗蛋白量
に対するGly m Bd30K量が0.5%以下で、0.22Mトリク
ロロ酢酸可溶窒素率が5〜30%である大豆蛋白分解物。
2. The ratio of 0.22M trichloroacetic acid-soluble nitrogen in which the ratio of the amount of glycinin to the amount of β-conglycinin in soybean protein is 5 or more and the amount of Gly m Bd30K is 0.5% or less relative to the amount of crude protein in soybean protein. Is a soy protein hydrolyzate containing 5 to 30%.
【請求項3】請求項1又は請求項2記載の大豆蛋白分解
物を蛋白原料の一部または全部として含有する大豆蛋白
分解物利用食品。
3. A soybean protein hydrolyzate-containing food containing the soybean protein hydrolyzate according to claim 1 or 2 as a part or all of a protein raw material.
【請求項4】低変性大豆蛋白を50℃を越え90℃未満及び
枯草菌に由来するプロテアーゼで分解することを特徴と
する大豆蛋白分解物の製造法。
4. A process for producing soybean protein hydrolyzate, characterized by degradation with a protease derived from a low-denatured soybean protein to 90 ° C. and less than Bacillus subtilis exceed 50 ° C..
【請求項5】低変性脱脂大豆のNSI(窒素可溶係数)が6
0以上である請求項4の製造法。
5. The NSI (nitrogen solubility coefficient) of low-denaturation defatted soybean is 6
The production method according to claim 4, which is 0 or more.
【請求項6】分解後の反応液のTCA%が5〜30%となるよ
うに分解する請求項4又は請求項5の製造法。
6. The method according to claim 4, wherein the reaction solution after decomposition is decomposed so that the TCA% becomes 5 to 30%.
【請求項7】pH=5〜10で5分〜2時間分解する請求項4
〜6のいずれかの製造法。
7. The method of decomposing at pH = 5 to 10 for 5 minutes to 2 hours.
6. The method according to any one of to 6.
JP35395897A 1997-12-24 1997-12-24 Soy protein hydrolyzate, method for producing the same, and foods using the same Expired - Fee Related JP3417461B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP35395897A JP3417461B2 (en) 1997-12-24 1997-12-24 Soy protein hydrolyzate, method for producing the same, and foods using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP35395897A JP3417461B2 (en) 1997-12-24 1997-12-24 Soy protein hydrolyzate, method for producing the same, and foods using the same

Publications (2)

Publication Number Publication Date
JPH11178512A JPH11178512A (en) 1999-07-06
JP3417461B2 true JP3417461B2 (en) 2003-06-16

Family

ID=18434369

Family Applications (1)

Application Number Title Priority Date Filing Date
JP35395897A Expired - Fee Related JP3417461B2 (en) 1997-12-24 1997-12-24 Soy protein hydrolyzate, method for producing the same, and foods using the same

Country Status (1)

Country Link
JP (1) JP3417461B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3486387B2 (en) * 2000-03-03 2004-01-13 社団法人県央研究所 Manufacturing method of tofu
KR102688761B1 (en) * 2016-03-03 2024-07-29 호유 가부시키가이샤 Soybean allergy antigen
KR20180130530A (en) 2016-04-08 2018-12-07 프라운호퍼 게젤샤프트 쭈르 푀르데룽 데어 안겐반텐 포르슝 에. 베. Techno-functional plant protein fractions from legumes or oil seeds
WO2022097745A1 (en) 2020-11-09 2022-05-12 天野エンザイム株式会社 Production method for meat-like processed food product
CN116217691A (en) * 2023-04-12 2023-06-06 东北农业大学 A Method for Improving the Functional Properties of Glycinin by Ultrasonic Synergistic Phosphorylation

Also Published As

Publication number Publication date
JPH11178512A (en) 1999-07-06

Similar Documents

Publication Publication Date Title
EP0797927B1 (en) Soybean protein hydrolysate, process for producing the same, and meat products and drinks using the same
Sun Enzymatic hydrolysis of soy proteins and the hydrolysates utilisation
EP1512328A1 (en) Soluble soy protein with superior functional properties
EP3801068B1 (en) Modified rapeseed protein isolate
JP3417461B2 (en) Soy protein hydrolyzate, method for producing the same, and foods using the same
Howell Enzymatic Modifications
KR100555221B1 (en) Method for producing high protein hydrolyzate
US7112424B2 (en) Process for the preparation of protein hydrolysate from legumes
Haard Enzymic modification of proteins in food systems
WO2002069733A1 (en) Process for preparation of protein-hydrolysate from soy flour
WO2002069732A1 (en) Process for preparation of protein hydrolysate from soy flour
US6896917B2 (en) Process for preparation of protein-hydrolysate from soy flour
RU2182437C1 (en) Method of preparing protein composition
JP2001211851A (en) Method for producing allergen-reduced soy protein food
JPWO2005120244A1 (en) Method for producing soy protein hydrolyzate
JP2736829B2 (en) Production method of protein hydrolyzate without unpleasant taste
Takacs et al. Mechanically deboned turkey meat with improved digestibility and biological value
Goertzen The enzymatic modification of a chickpea protein isolate for improved nutritional and functional properties
JP3405144B2 (en) Method for producing soy protein hydrolyzate
JP3289770B2 (en) Proteolysate and method for producing the same
Hajós Enzymatic Modification as a Tool for Alteration of Safety and
US6420133B1 (en) Process for the preparation of a high protein hydrolysate
KR20040048650A (en) process for preparing hydrolysates as seasoning agents from the egg white and hydrolysates obtained by said process
RU2083142C1 (en) Method for preparing soya concentrate
Yaputri Characterization and Modification of Scaled-Up Pea and Chickpea Protein Isolates Extracted using Salt Solubilization Coupled with Membrane Filtration in Comparison to Commercial Proteins

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080411

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090411

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100411

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110411

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110411

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120411

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130411

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130411

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130411

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees